• Emergency :

    0484-290 5100

  • Appointments :

    0484-290 5111, 718 4111

  • Enquiry :

    0484-290 5000, 718 4000

Dr. Arun Philip

Dr. Arun Philip

Senior Consultant - Medical And Hemato Oncology

MD - General Medicine
DM - Medical Oncology
DNB - Medical Oncology

Dr. Arun Philip did his undergraduate training in medicine from Kottayam Medical College, Kerala and completed his postgraduate training (MD) in Internal Medicine from Kasturba Medical College, Mangalore during May 2006 - April 2009.

read more +

Later he joined the Adyar Cancer Institute, Chennai for his superspeciality training (DM) in Medical Oncology in June 2010. During his three-year tenure at the Adyar Cancer Institute, he got trained in the medical management of various malignancies.

Read less -


  • Worked in the department of Medical oncology as teaching faculty for 7 years and was examiner for DM & DNB medical oncology at Amrita Institute of Medical Sciences, Kochi.


  • Uro-oncology
  • Breast and Gynec oncology
  • Lung malignancies, Colorectal Cancer
  • Pediatric oncology


  • Ovarian germ cell tumours : An update on newer treatment paradigms : Arun Philip, Anupama R, Vijaykumar DK, Pavithran KP: Amrita Journal of medicine: July 2016 
  • Treatment outcome in medulloblastoma with the POG 9031 protocol : a single institution review. A. Philip et al: Ann Oncol (2016) 27 (suppl_6): 334P.
  • A Study on Clinical Pharmacist’s Interventions in the Management of Febrile Neutropenia in A Tertiary Care Hospital. Amrutha V. Ajai, K. Aditi, Aswani Sreekumar, Amitha Serah Mathew, Siby Joseph, Arun Philip. IJPRR 2016;5(9)
  • Response and Survival in Newly Diagnosed Multiple Myeloma Patients treated with Cybord Regimen Using Generic Bortezomib — Data from two Centres from India : Neeraj Sidharthan, Akhila Sivadas, Anup Joseph Devasia, Uday Prakash Kulkarni, Remya Sudevan,Keechilat Pavithran, Raghuveer Prabhu, Rema Ganapathy, Arun Philip, Wesley Jose, Manoj Unni, Anu Korula,Nisham PN, Aby Abraham, Alok Srivastava, Vikram Mathews, Biju George: Blood 2017; 130:5398
  • Is there a role for adjuvant radiation in T1N0 squamous cell carcinoma tongue with adverse pathological features? Factors affecting local control and the development of a scoring system. Vijay Kumar Srinivasalu, Narayana Subramaniam, Deepak Balasubramanian, Hubert Low, Adharsh Anand, Krishnakumar Thankappan, Arun Philip, Subramania Iyer,Keechilat Pavithran. Journal of Clinical Oncology 2017 35:15_suppl
  • Robot-assisted supine extraperitoneal retroperitoneal lymphnode dissection: a novel approach for template dissection in postchemotherapyresidual mass in non-seminomatous germ cell tumours : Pooleri, G.K., Bijalwan, P., Kesavan, R., Philip A., Keechilat P. J Robotic Surg. 2018. 10.1007 
  • Pharmacogenetic landscape of DPYD variants in south Asian populations by integration of genome-scale data : Judith M Hariprakash, Shamsudheen K Vellarikkal, Pavithran Keechilat, Ankit Verma, Rijith Jayarajan, Vishal Dixit, Rowmika Ravi, Vigneshwar Senthivel, Anoop Kumar, Paras Sehgal, Aradhana, Akhilesh K Sonakar, Sakshi Ambawat, Ani K Giri, Arun Philip, Akhila Sivadas, Mohammed Faruq, Dwaipayan Bharadwaj, Sridhar, Sivasubbu, Vinod Scaria : Pharmacogenomics. 2018 Feb;19(3):227-241. doi: 10.2217/pgs-2017-0101.
  • Prognostic significance of residual nodal burden using lymph node ratio in locally advanced breast cancer after neoadjuvant chemotherapy. Reshu Agarwal, Arun Philip, Keechilat Pavithran, Anupama Rajanbabu, Gaurav Goel, DK Vijaykumar. Indian J Cancer 2019;56:228-35
  • Concurrent chemoradiotherapy for head and neck cancers in older patients: Outcomes and their determinants. Srinivasalu VK, Subramaniam N, Balasubramanian D, Kumar N, Philip A, Susan A, Pushpaja K U, Nair AR, Thankappan K, Jose W, Iyer S, Keechilat P.  Indian J Cancer 2019;56:261-6. 
  • FLOT versus EOX in first line treatment of metastatic carcinoma of stomach. Srinivasalu Vijay, Subramaniam Narayana, Jose Wesley, Philip A, Pavithran Keechilat. 2018. Annals of Oncology. 29. 10.1093/annonc/ mdy432.015.
  • A prospective study of the impact of chemotherapy-related toxicities on the quality of life in elderly patients with cancer. Kotne Sanketh, Ponnada Bharadwaj, Philip Arun, Pavithran Keechilat. Journal of Clinical Oncology.2019. 37. e23013-e23013. 10.1200/JCO.2019.37.15
  • Nivolumab induced cutaneous reactions in a patient with lung cancer– A case study. VP Anukrishna, Subhash Athulya, Philip Arun, Pavithran Keechilat, Reghu Remya. International Journal of Research in Pharmaceutical Sciences.2020. 11. 7376-7379. 10.26452/ijrps.v11i4.3920.
  • Neoadjuvant chemotherapy in muscle invasive bladder cancer: Real world data on safety and outcome. Panthula Sree, Philip Arun, Pavithran Keechilat, Jose Wesley. 2020. Journal of Clinical Oncology. 38. e17036-e17036. 10.1200/JCO.2020.38.15_suppl.e17036.
  • Recurrence of renal cell carcinoma after three decades in an octogenarian: Small molecules adding life to years. Philip A, Jojo A, Keechilat P. J Can Res Ther. 2020.Nov
  • Pemetrexed-Associated Hyperpigemented Skin Rash. David Emil, Krishna Rakhi, Ramachandran Lakshmi, Raghuram Y Saadvik, Philip Arun, Pavithran Keechilat. 2020. American Journal of Therapeutics. 1.10.1097/ MJT. 0000000000001146.
  • Pretreatment neutrophil to lymphocyte ratio predicts lymph node metastasis in triple negative breast cancer. Philip A, Jose M, Jose WM, Vijaykumar DK, Pavithran K.. Indian J Cancer. 2021
  • Triple intrathecal chemotherapy for leptomeningeal carcinomatosis in solid tumors: Treatment outcomes, response and their determinants. Srinivasalu VK, Subramaniam N, Philip A, Jose W, Pavithran K.. Indian J Cancer 2021; 58:84-90
  • Sarada K, Puthiyedath R, Philip A, Ravindran GC, Pavithran K. Prevalence of the use of traditional complementary and alternative medicine amongst cancer patients in a tertiary care center in Kerala, India. J Ayurveda Integr Med. 2021 Apr-Jun;12(2):359-364. doi: 10.1016/j.jaim.2021.04.011. Epub 2021 May 18. PMID: 34016499


  • Gold medal in the DM medical oncology exit exam conducted by the MGR Medical University, TN at Adyar Cancer Institute, Chennai 
  • Cleared the DNB National Boards in Medical Oncology : 2014 -15 session
  • Appointed as DM / DNB examiner in Medical Oncology 2020.


  • European Society of Medical Oncology
  • Indian Society of Medical & Pediatric Oncology
  • Indian Medical Association.
  • Association of Medical and Pediatric oncology of Kerala

Testimonials What Our Patient Say